written on 16.06.2014
pt:
Tags:
,

Dealing with Human Error in Life Sciences

TAGS: ,

We recently came across an interesting case that raised the question of how we should deal with human error in life sciences. This unprecedented legal case, ”…the first in which a structural reassignment puts in jeopardy a patent and clinical trials…” can be found here. The story: Oncoceutics announced that their proprietary drug ONC-201 (also […]

Latest Report